|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/737 |
| (11) | Number of the document | 2953630 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14707953.7 |
| Date of filing the European patent application | 2014-02-07 | |
| (97) | Date of publication of the European application | 2015-12-16 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/052406 |
| Date | 2014-02-07 |
| (87) | Number | WO 2014/122251 |
| Date | 2014-08-14 |
| (30) | Number | Date | Country code |
| 201361762718 P | 2013-02-08 | US | |
| 201361811526 P | 2013-04-12 | US |
| (72) |
KLINGER, Matthias, DE
HOFFMANN, Patrick, DE
NAEGELE, Virginie, DE
DOPFER, Elaine-Pashupati, DE
NAGORSEN, Dirk, DE
SCHEELE, Juergen, DE
ZUGMAIER, Gerhard, DE
KUFER, Peter, DE
|
| (73) |
Amgen Research (Munich) GmbH,
Staffelseestrasse 2, 81477 München,
DE
|
| (54) | ANTI-LEUKOCYTE ADHESION FOR THE MITIGATION OF POTENTIAL ADVERSE EVENTS CAUSED BY CD3-SPECIFIC BINDING DOMAINS |
| ANTI-LEUKOCYTE ADHESION FOR THE MITIGATION OF POTENTIAL ADVERSE EVENTS CAUSED BY CD3-SPECIFIC BINDING DOMAINS |